Oklahoma Center for Microbial Pathogenesis and Immunity
俄克拉荷马州微生物发病机制和免疫中心
基本信息
- 批准号:10554351
- 负责人:
- 金额:$ 215.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-01 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAreaBacterial InfectionsBacterial ToxinsBiologyBiomedical ResearchCareer MobilityCellular ImmunityCenters of Research ExcellenceCessation of lifeCollaborationsCommunicable DiseasesCommunitiesDataDisciplineDiseaseEducational workshopElementsEnsureEnvironmentEventEye InfectionsFacultyFosteringFoundationsFundingFutureGeneticGoalsGram-Positive BacteriaGrantHealthHealth SciencesHospitalsHumanImmune responseImmune systemImmunityImmunologyInfectionInflammationInfrastructureInstitutionLaboratory ResearchLifeMentorsMicrobeMicrobial BiofilmsMicrobiologyMissionModernizationMolecularNecrotizing EnterocolitisOklahomaPathogenesisPhasePilot ProjectsProductivityProgram SustainabilityRegulationResearchResearch InfrastructureResearch PersonnelResearch PriorityResearch Project GrantsResourcesScienceScientistStrategic PlanningStructureTechnologyTherapeuticTrainingTranslatingUnited States National Institutes of HealthUniversitiesWorkWritingadaptive immunitycareercareer developmentcohortcollaborative environmentgut colonizationimprovedinnovationmicrobialmicrobiomemultidisciplinarynewsoutreachpathogenpathogenic fungusprogramsrecruitsuccesssymposiumtranscriptome
项目摘要
Abstract
The goal of this Phase-1 COBRE program is to develop and enhance the research
infrastructure, mentoring, and collaborative environment to support five Junior Investigators in
the multi-disciplinary fields of microbial pathogenesis and immunity. To achieve this goal, The
Oklahoma Center for Microbial Pathogenesis and Immunity (OCMP&I) COBRE will be
established and fostered as a center of excellence focused on advancing the careers of Junior
Investigators studying life-threatening infectious microbes and the ways in which the immune
system responds to infection. The OCMP&I COBRE will be centrally located at the University of
Oklahoma Health Sciences Center, the flagship academic institution for biomedical research in
Oklahoma. The OCMP&I COBRE will initially include 17 scientists engaged in microbial
pathogenesis and immunity research at research-intensive institutions in Oklahoma and this
network will be expanded during the Phase-1 period as the center takes form and grows.
Among these 17 scientists are five outstanding and promising Junior Investigators who study
fungal pathogenesis, inflammation, regulation of biofilms, and necrotizing enterocolitis. The
OCMP&I and its consortium of successful senior researcher scientists will provide the
intellectual input and expertise to mentor each Junior Investigator to research independence. In
addition to outstanding mentoring, The OCMP&I COBRE will provide the funding and research
core support needed for Junior Investigators to succeed and become long-term contributors to
the microbial pathogenesis and immunity research community in Oklahoma. Intertwined with
the Junior Investigator support, will be the OCMP&I COBRE's mission to address gaps in
infrastructure and resources that have limited the opportunities for cutting-edge research in our
state. To achieve these objectives, the OCMP&I COBRE will be guided by four overall specific
aims. Specific Aim 1: Establish a thematic center to enhance research, mentoring, and
infrastructure support for microbial pathogenesis and immunity research in Oklahoma, Specific
Aim 2: Select and support outstanding Junior Investigators, Specific Aim 3: Expand and
enhance infrastructure to support innovative and collaborative research in microbial
pathogenesis and immunity in Oklahoma. Specific Aim 4: Foster a culture of collaboration and
team-science by providing opportunities for frequent scholarly interactions and outreach through
seminars, symposiums, workshops, and pilot projects. Key elements for the success of the
center include 1) the establishment of a single, but highly facile research core, that can
immediately support the first group of Junior Investigator projects and expand to meet ever-
changing research needs of investigators in microbial pathogenesis and immunity, 2) up date
and modernize research laboratory space where Junior Investigators can work with established
investigators and benefit from daily interactions, 3) Develop a pipeline of future Junior
Investigators through targeted hires and through collaboration with a network of departmental
leaders on multiple campuses, 4) Utilize and capitalize on current IDeA program resources in
Oklahoma, and 5) Utilize an ongoing seminar program, sponsor a new annual symposium, and
support a grant-writing workshop to encourage collaborative interactions and exchange of ideas
among investigators in this multi-disciplinary area of research. Collectively, this five-year
Phase-1 COBRE program will establish the first center of research excellence in Oklahoma
focused on microbial pathogenesis and immunity and become the central entity that accelerates
research by all investigators in these fields and provides a highly-supportive path to
independence for our most promising Junior Investigators.
抽象的
第一阶段 COBRE 计划的目标是发展和加强研究
基础设施、指导和协作环境,以支持五名初级研究员
微生物发病机制和免疫的多学科领域。为了实现这一目标,
俄克拉荷马州微生物发病机制和免疫中心 (OCMP&I) COBRE 将
建立并培育成为一个专注于促进青少年职业发展的卓越中心
研究人员正在研究危及生命的传染性微生物以及免疫系统的作用方式
系统对感染做出反应。 OCMP&I COBRE 将位于大学的中心
俄克拉荷马州健康科学中心,美国生物医学研究的旗舰学术机构
俄克拉荷马州。 OCMP&I COBRE 最初将包括 17 名从事微生物研究的科学家
俄克拉荷马州研究密集型机构的发病机制和免疫研究
随着中心的形成和发展,网络将在第一阶段得到扩展。
在这 17 名科学家中,有 5 名杰出且有前途的初级研究员,他们的研究
真菌发病机制、炎症、生物膜调节和坏死性小肠结肠炎。这
OCMP&I 及其成功的高级研究科学家联盟将提供
指导每个初级研究员独立研究的智力投入和专业知识。在
除了出色的指导外,OCMP&I COBRE 还将提供资金和研究
初级研究者取得成功并成为长期贡献者所需的核心支持
俄克拉荷马州的微生物发病机制和免疫研究团体。交织在一起
初级研究员的支持将是 OCMP&I COBRE 的使命,旨在解决
基础设施和资源限制了我们进行尖端研究的机会
状态。为了实现这些目标,OCMP&I COBRE 将遵循四个总体具体目标
目标。具体目标 1:建立一个专题中心,以加强研究、指导和
俄克拉荷马州微生物发病机制和免疫研究的基础设施支持,具体
目标 2:选择和支持优秀的初级研究者,具体目标 3:扩大和
加强基础设施以支持微生物领域的创新和合作研究
俄克拉荷马州的发病机制和免疫。具体目标 4:培养协作文化
团队科学,通过提供频繁的学术互动和外展机会
研讨会、专题讨论会、讲习班和试点项目。成功的关键要素
中心包括 1) 建立一个单一但高度便利的研究核心,可以
立即支持第一组初级研究员项目并扩大以满足永远的需求
微生物发病机制和免疫领域研究者的研究需求不断变化,2) 更新
并使研究实验室空间现代化,初级研究人员可以与已建立的实验室一起工作
调查员并从日常互动中受益,3)开发未来初级人才的管道
调查人员通过有针对性的雇用以及与部门网络的合作
多个校区的领导者,4) 利用和利用当前的 IDeA 项目资源
俄克拉荷马州,以及 5) 利用正在进行的研讨会计划,赞助新的年度研讨会,以及
支持资助写作研讨会,以鼓励协作互动和思想交流
在这个多学科研究领域的研究人员中。总的来说,这五年
第一阶段 COBRE 计划将在俄克拉荷马州建立第一个卓越研究中心
专注于微生物发病机制和免疫,成为加速发展的核心实体
这些领域的所有研究人员的研究,并提供了一个高度支持的途径
我们最有前途的初级研究人员的独立性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jimmy D. Ballard其他文献
A toxin contest
一场毒素竞赛
- DOI:
10.1038/467665a - 发表时间:
2010-10-06 - 期刊:
- 影响因子:48.500
- 作者:
Jimmy D. Ballard - 通讯作者:
Jimmy D. Ballard
CSPG4-dependent cytotoxicity for emC. difficile/em TcdB is influenced by extracellular calcium and chondroitin sulfate
艰难梭菌 TcdB 对 emC 的 CSPG4 依赖性细胞毒性受细胞外钙和硫酸软骨素的影响
- DOI:
10.1128/msphere.00094-24 - 发表时间:
2024-03-12 - 期刊:
- 影响因子:3.100
- 作者:
D. Annie Doyle;Paul L. DeAngelis;Jimmy D. Ballard;Sarah E. F. D'Orazio - 通讯作者:
Sarah E. F. D'Orazio
Critical intermediate steps in <em>Clostridium sordellii</em> lethal toxin-induced apoptosis
- DOI:
10.1016/j.bbrc.2007.09.073 - 发表时间:
2007-11-30 - 期刊:
- 影响因子:
- 作者:
Daniel E. Voth;Jimmy D. Ballard - 通讯作者:
Jimmy D. Ballard
A toxin contest
一场毒素竞赛
- DOI:
10.1038/467665a - 发表时间:
2010-10-06 - 期刊:
- 影响因子:48.500
- 作者:
Jimmy D. Ballard - 通讯作者:
Jimmy D. Ballard
Jimmy D. Ballard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jimmy D. Ballard', 18)}}的其他基金
Oklahoma C. difficile U19 Challenge Core
俄克拉荷马州艰难梭菌 U19 挑战核心
- 批准号:
10625174 - 财政年份:2023
- 资助金额:
$ 215.74万 - 项目类别:
Enhancing C. difficile vaccination in the context of TcdB-mediated immunosuppression.
在 TcdB 介导的免疫抑制背景下加强艰难梭菌疫苗接种。
- 批准号:
10625175 - 财政年份:2023
- 资助金额:
$ 215.74万 - 项目类别:
Oklahoma Center for Microbial Pathogenesis and Immunity
俄克拉荷马州微生物发病机制和免疫中心
- 批准号:
10341201 - 财政年份:2020
- 资助金额:
$ 215.74万 - 项目类别:
Differential Effects of TcdB1 and TcdB2 in C. difficile disease
TcdB1 和 TcdB2 在艰难梭菌疾病中的不同作用
- 批准号:
10094178 - 财政年份:2015
- 资助金额:
$ 215.74万 - 项目类别:
Differential Effects of TcdB1 and TcdB2 in C. difficile disease
TcdB1 和 TcdB2 在艰难梭菌疾病中的不同作用
- 批准号:
8945312 - 财政年份:2015
- 资助金额:
$ 215.74万 - 项目类别:
Differential Effects of TcdB1 and TcdB2 in C. difficile disease
TcdB1 和 TcdB2 在艰难梭菌疾病中的不同作用
- 批准号:
10331732 - 财政年份:2015
- 资助金额:
$ 215.74万 - 项目类别:
Differential Effects of TcdB1 and TcdB2 in C. difficile disease
TcdB1 和 TcdB2 在艰难梭菌疾病中的不同作用
- 批准号:
10548849 - 财政年份:2015
- 资助金额:
$ 215.74万 - 项目类别:
Edema Toxin Suppression of Immune Responses During Anthrax Disease
炭疽病期间水肿毒素抑制免疫反应
- 批准号:
7695606 - 财政年份:2009
- 资助金额:
$ 215.74万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 215.74万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 215.74万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 215.74万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 215.74万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 215.74万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 215.74万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 215.74万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 215.74万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 215.74万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 215.74万 - 项目类别:
Research Grant